-
2-amino-3-hydroxy-N'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide hydrochloride
-
ChemBase ID:
73027
-
Molecular Formular:
C10H16ClN3O5
-
Molecular Mass:
293.70414
-
Monoisotopic Mass:
293.07784831
-
SMILES and InChIs
SMILES:
c1(c(c(c(cc1)CNNC(=O)C(N)CO)O)O)O.Cl
Canonical SMILES:
OCC(C(=O)NNCc1ccc(c(c1O)O)O)N.Cl
InChI:
InChI=1S/C10H15N3O5.ClH/c11-6(4-14)10(18)13-12-3-5-1-2-7(15)9(17)8(5)16;/h1-2,6,12,14-17H,3-4,11H2,(H,13,18);1H
InChIKey:
ULFCBIUXQQYDEI-UHFFFAOYSA-N
-
Cite this record
CBID:73027 http://www.chembase.cn/molecule-73027.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
2-amino-3-hydroxy-N'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide hydrochloride
|
|
|
IUPAC Traditional name
|
benserazide hydrochloride
|
|
|
Synonyms
|
Serazide
|
Ro 4-4602
|
Benserazide hydrochloride
|
DL-Serine 2-(2,3,4-trihydroxybenzyl)hydrazide hydrochloride
|
Benserazide hydrochloride
|
DL-Serine 2-[(2,3,4-Trihydroxyphenyl)methyl]hydrazide Hydrochloride
|
DL-Serine N2-(2,3,4-trihydroxybenzyl)hydrazide Hydrochloride
|
N-(DL-Seryl)-N'-(2,3,4-trihydroxybenzyl)hydrazine Hydrochloride
|
Ro-4-4602
|
DL-SERINE 2
|
BENSERAZIDE
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
8.688219
|
H Acceptors
|
7
|
H Donor
|
7
|
LogD (pH = 5.5)
|
-3.9209604
|
LogD (pH = 7.4)
|
-2.2601278
|
Log P
|
-1.9928483
|
Molar Refractivity
|
73.2301 cm3
|
Polarizability
|
24.415533 Å3
|
Polar Surface Area
|
148.07 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
MP Biomedicals
Selleck Chemicals
Sigma Aldrich
TRC
Selleck Chemicals -
S2453
|
Research Area: Neurological Disease Biological Activity: Benserazide is a peripherally-acting aromatic L-amino acid decarboxylase (AAAD) or DOPA decarboxylase inhibitor. It inhibits this decarboxylation, and since it itself cannot cross the blood-brain barrier, this allows dopamine to build up solely in the brain instead. Adverse effects caused by peripheral dopamine, such as nausea and arrhythmia, are minimized. However, benserazide cannot reduce the centrally-mediated side effects of levodopa, particularly dyskinesia. [1][2] |
Sigma Aldrich -
B7283
|
Biochem/physiol Actions Inhibitor of L-aromatic amino acid decarboxylase. |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • http://en.wikipedia.org/wiki/Benserazide
- • Burkard, W.P., et al.: Experientia, 18, 411 (1962)
- • Marion, M.-H., et al.: Adv. Neurol., 45, 493 (1962)
- • Pinder, R.M., et al.: Drugs, 11, 329 (1976)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent